• About Us
  • Board of Advisors
  • Contact

MALARIA.com

A Malaria Information and Community Portal

  • Home
  • Malaria Overview
  • Malaria Research
  • News
  • Videos
  • Blogs
  • Malaria Q&A
  • Events
  • Jobs
Home / Malaria Q&A / Anti-Malarial Tablets for Kenya

Anti-Malarial Tablets for Kenya

October 22, 2011 By Malaria Q&A Leave a Comment

QUESTION

Which are the best tablets to take against malaria in Kenya?
Is there a malaria vaccination?

ANSWER

I’ll answer your second question first—no, there does not yet exist a commercially available malaria vaccine. Currently, one promising vaccine candidate is undergoing Phase 3 clinical trials in children in sub-Saharan Africa; recently published preliminary findings suggest that it provides roughly 50% protection against malaria.

As for which tablets you should take, there are a number of options, and choosing between them is basically a matter of personal preference. The three main kinds recommended for sub-Saharan Africa are doxycycline, atovaquone/proguanil combination (sold under the brand name Malarone) and mefloquine (sold as Lariam). These three differ in how you take them (usually once a day for doxycycline and Malarone and once a week for Lariam), how expensive they are (doxycycline is the cheapest, Malarone the most expensive) and the side effects you might experience (sun sensitivity is a big problem for some people on doxycycline, some people report hallucinations on Lariam, whereas Malarone usually has the fewest severe side effects).

If you’re not sure what’s best for you, you can always talk it over with your doctor when asking for the prescription, and they might have recommendations, based on their knowledge of your health and specific requirements.

It is worth noting that levels of chloroquine resistance are very high in sub-Saharan Africa, and so chloroquine is not recommended as a prophylactic when travelling to this region.

Filed Under: Malaria Q&A Tagged With: atovaquine, Chloroquine, Chloroquine-Resistant Malaria, Doxycycline, Lariam, Malarone, Mefloquine, Plasmodium Falciparum, proguanil

Leave a Reply Cancel reply

You must be logged in to post a comment.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Stay Informed

WWARN Corner

About WWARN

The WorldWide Antimalarial Resistance Network (WWARN) generates innovative resources and reliable evidence to inform the malaria community on the factors affecting the efficacy of antimalarial medicines. Learn more…

  • Fighting Malaria Requires Protecting the Effectiveness of Antimalarial Medicines
  • Data Sharing at IDDO
  • Evidence to inform equitable dosing in very young and malnourished children

More WWARN Stories...

Five Things You Might Not Know About Medicine Quality

The proliferation of poor quality medicines has been described as a global pandemic that threatens the lives of millions.1 It stands to reason that poor quality medicines are not going to improve anyone’s health, but how much do we really know about the quality of medicines used across the world? Here we examine five issues relating to medicine quality in an effort to show why we should all be paying more attention to a serious public health issue that is difficult to tackle and not yet fully understood.

How Can We Detect Poor Quality Medicines?

Finding out what medicines contain and investigating their packaging are vital steps in the fight against poor quality medicines, both substandard and falsified. Falsified medicines usually masquerade as real medicines by copying the appearance and packaging of the real product, but may not contain any of the same active ingredients, or in the correct amounts.

Challenges in Tackling the Issue of Poor Quality Medicines

There are many unresolved issues that impede the elimination of poor quality medicines, namely: (1) Progress impeded by confusion over definitions; Ensuring a market free of poor quality medicines; and the lack of global criminal laws.

Editorial

Antimicrobial Resistance: The Silent Threat in Malaria Eradication

By Bernard Owusu Agyware, Arielle Dolegui and Jesus Aquilar Malaria is a serious and sometimes deadly disease, affecting millions and claiming more than  600,000 lives worldwide each year in 2022 and 2021.1 Low and Middle-Income Countries (LMICs), particularly in Sub-Saharan Africa, disproportionately bear the greatest burden of malaria. The fight to eradicate this worrisome disease […]

  • Home
  • Malaria Overview
  • Malaria Research
  • News
  • Videos
  • Blogs
  • Malaria Q&A
  • Events
  • Jobs
  • About Us
  • Board of Advisors
  • Contact

Copyright © 2026 Malaria.com · Log in